Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GeneDx

< Previous 1 2 3 Next >
News headline image
GeneDx Research Demonstrates Medical Actionability of Exome and Genome Sequencing Results in Large Real-World Study of More Than 300,000 Patients
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Reports Third Quarter 2026 Financial Results
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Reports Second Quarter 2026 Financial Results
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
From GeneDx
Via Business Wire
Tickers WGS
News headline image
Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
Tickers WGS
News headline image
INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
From GeneDx
Via Business Wire
Tickers WGS
News headline image
TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
From GeneDx
Via Business Wire
Tickers WGS
News headline image
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
From GeneDx
Via Business Wire
Tickers WGS
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.